Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Laufer

Showing results (121-130 of 189) with videos related to

Pageof 19
Sort By:
Molecules (Basel, Switzerland)|June 28, 2019
Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β InhibitorsStanislav Andreev, Tatu Pantsar, Francesco Ansideri, et al.
Orphanet Journal of Rare Diseases|January 23, 2025
Sprengel deformity: What is the functional outcome of conservative treatment versus surgical correction?C Antfang, A Frommer, G Gosheger, et al.
Epidemiology and Infection|July 11, 2018
Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaignA Laufer Halpin, W Gu, M E Wise, et al.
Case Reports in Orthopedics|May 19, 2021
Fibula-Assisted Segment Transport (FAST) for Defect Reconstruction after Resection of Tibial Adamantinoma: Report of Two TreatmentsA Rachbauer, A Laufer, G Gosheger, et al.
Journal of Medicinal Chemistry|September 2, 2009
Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX)Andy J Liedtke, Peter R W E F Keck, Frank Lehmann, et al.
Journal of Medicinal Chemistry|September 21, 2012
Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOXMahmoud Elkady, Raimund Nieß, Anja M Schaible, et al.
Clinical Nephrology|April 22, 2017
Mortality risk factors in intensive care unit patients with acute kidney injury requiring renal replacement therapy: a retrospective cohort study
Michael Schmitz, Frank P Tillmann, Ausra Paluckaite, et al.
Human Molecular Genetics|August 4, 2022
A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South AfricaEvans M Mathebula, Dhriti Sengupta, Nimmisha Govind, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Discovery of Polyphenolic Natural Products as SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19Nadine Krüger, Thales Kronenberger, Hang Xie, et al.
Journal of Medicinal Chemistry|July 2, 2014
Development of first lead structures for phosphoinositide 3-kinase-C2γ inhibitorsAnne Freitag, Prajwal Prajwal, Aliaksei Shymanets, et al.
Pageof 19

Showing results (121-130 of 189) with videos related to

Sort By:
Pageof 19
Molecules (Basel, Switzerland)|June 28, 2019
Design, Synthesis and Biological Evaluation of 7-Chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole-based Glycogen Synthase Kinase-3β InhibitorsStanislav Andreev, Tatu Pantsar, Francesco Ansideri, et al.
Orphanet Journal of Rare Diseases|January 23, 2025
Sprengel deformity: What is the functional outcome of conservative treatment versus surgical correction?C Antfang, A Frommer, G Gosheger, et al.
Epidemiology and Infection|July 11, 2018
Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaignA Laufer Halpin, W Gu, M E Wise, et al.
Case Reports in Orthopedics|May 19, 2021
Fibula-Assisted Segment Transport (FAST) for Defect Reconstruction after Resection of Tibial Adamantinoma: Report of Two TreatmentsA Rachbauer, A Laufer, G Gosheger, et al.
Journal of Medicinal Chemistry|September 2, 2009
Arylpyrrolizines as inhibitors of microsomal prostaglandin E2 synthase-1 (mPGES-1) or as dual inhibitors of mPGES-1 and 5-lipoxygenase (5-LOX)Andy J Liedtke, Peter R W E F Keck, Frank Lehmann, et al.
Journal of Medicinal Chemistry|September 21, 2012
Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOXMahmoud Elkady, Raimund Nieß, Anja M Schaible, et al.
Clinical Nephrology|April 22, 2017
Mortality risk factors in intensive care unit patients with acute kidney injury requiring renal replacement therapy: a retrospective cohort study
Michael Schmitz, Frank P Tillmann, Ausra Paluckaite, et al.
Human Molecular Genetics|August 4, 2022
A genome-wide association study for rheumatoid arthritis replicates previous HLA and non-HLA associations in a cohort from South AfricaEvans M Mathebula, Dhriti Sengupta, Nimmisha Govind, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
Discovery of Polyphenolic Natural Products as SARS-CoV-2 M<sup>pro</sup> Inhibitors for COVID-19Nadine Krüger, Thales Kronenberger, Hang Xie, et al.
Journal of Medicinal Chemistry|July 2, 2014
Development of first lead structures for phosphoinositide 3-kinase-C2γ inhibitorsAnne Freitag, Prajwal Prajwal, Aliaksei Shymanets, et al.
Pageof 19